Can a daily supplement ease the toll of duchenne muscular dystrophy?
NCT ID NCT07766980
First seen Aug 17, 2026 · Last updated Aug 17, 2026
Summary
This pilot study tests whether VM100, a nutritional supplement made from ten natural ingredients, can improve quality of life for people with Duchenne muscular dystrophy (DMD). About 20 participants aged 8 and older will take VM100 or a placebo for 10 weeks. Researchers will measure changes in physical symptoms, mental well-being, cognitive function, and fatigue using questionnaires and interviews.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- VM100, an investigational nutritional supplement with ten naturally derived ingredients designed to support mitochondrial function, reduce inflammation and oxidative stress, and improve cognitive function and mood.
- What this could lead to
- If effective, VM100 could offer a safe, accessible way to ease physical symptoms and boost mental well-being in people with Duchenne muscular dystrophy, potentially improving daily life.
- What could go wrong
- This is a small pilot study, so results may not be conclusive. The supplement's benefits are unproven, and it may not work for everyone or could cause unexpected side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DMD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Florida
RECRUITINGGainesville, Florida, 32610, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a lower steroid dose preserve strength in young boys with DMD?
- Can a targeted infusion slow muscle decline in duchenne? a new trial aims to find out.
- Can a massive patient database unlock new treatments for muscular dystrophy?
- Umbilical cord stem cells aim to slow muscle loss in duchenne boys
- Experimental drug aims to preserve arm and lung function in boys with advanced duchenne
- Experimental drug KER-065 aims to slow muscle decline in duchenne muscular dystrophy